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Background

Current studies show similar in-hospital outcomes following percutaneous coronary intervention (PCI)
between Black and White patients. Long-term outcomes and the role of individual and community-level socioeconomic factors
in differential risk are less understood.

Methods

We linked clinical registry data from PCIs performed between January, 2013 and March, 2018 at 48 Michigan hospitals to Medicare Fee-for-service claims. We analyzed patients of Black and White race. We used propensity score
matching and logistic regression models to estimate the odds of 90-day readmission and Cox regression to evaluate the risk
of postdischarge mortality. We used mediation analysis to evaluate the proportion of association mediated by socioeconomic
factors.

Results

Of the 29,317 patients included in this study, 10.28% were Black and 89.72% were White. There were minimal
differences between groups regarding post-PCI in-hospital outcomes. Compared with White patients, Black patients were more
likely to be readmitted within 90-days of discharge (adjusted OR 1.62, 95% CI [1.32-2.00]) and had signiﬁcantly higher
risk of all-cause mortality (adjusted HR 1.45, 95% CI 1.30-1.61) when adjusting for age and gender. These associations
were signiﬁcantly mediated by dual eligibility (proportion mediated [PM] for readmission: 11.0%; mortality: 21.1%); dual
eligibility and economic well-being of the patient’s community (PM for readmission: 22.3%; mortality: 43.0%); and dual
eligibility, economic well-being of the community, and baseline clinical characteristics (PM for readmission: 45.0%; mortality:
87.8%).

Conclusions

Black patients had a higher risk of 90-day readmission and cumulative mortality following PCI compared
with White patients. Associations were mediated by dual eligibility, community economic well-being, and traditional cardiovascular risk factors. Our study highlights the need for improved upstream care and streamlined postdischarge care pathways
as potential strategies to improve health care disparities in cardiovascular disease. (Am Heart J 2022;255:106–116.)
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Racial disparities in the management and outcomes
of cardiovascular diseases like coronary artery disease
(CAD) and acute myocardial infarction (AMI) are welldocumented and pervasive.1–7 For instance, Black patients are less likely to be referred for invasive angiography8 , 9 and undergo percutaneous revascularization5
compared with White patients.
Racial disparities in long-term outcomes following percutaneous coronary intervention (PCI) are less understood. Some investigations have shown short and longterm outcomes following PCI vary by race and are
not fully explained by differences in baseline risk factors,10–13 while others have failed to show an association
with post-PCI outcomes once accounting for comorbid-
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ity burden.3 , 14–16 Importantly, very few studies to date
have addressed the gap in our understanding of the social
and economic drivers of racial disparities in PCI that are
not captured by traditional cardiovascular risk factors.10
Knowledge of such factors is critical for developing interventions to achieve better health equity and mitigate
excess risk associated with PCI in Black patients.17
In this context, we sought to evaluate the association
between race and postdischarge PCI outcomes, including 90-day readmission and mortality, using contemporary data from all PCIs performed at nonfederal hospitals
in the state of Michigan. We hypothesize that Black patients undergoing PCI have higher rates of adverse longterm outcomes after PCI compared with White patients.
We also hypothesize that variation in outcomes between
Black and White patients is mediated by personal socioeconomic status and community-level economic wellbeing of the patient and hospital, in addition to differences in baseline clinical characteristics and comorbidities.

Methods
We performed a retrospective analysis using data from
the Blue Cross Blue Shield of Michigan Cardiovascular
Consortium (BMC2), a multicenter, statewide registry of
patients who underwent PCI at 48 nonfederal hospitals
in Michigan. The details of this registry, including the abstraction and auditing process, have been previously described.18 19 The University of Michigan Institutional Review Board has approved the research conducted in this
registry as not meeting the definition of research requiring informed consent.
We linked the BMC2 clinical PCI data with Medicare
fee-for-service 90-day episodes of care made available
through the Michigan Value Collaborative (MVC). The 2
data sources and matching algorithm have been previously described in detail.20 Briefly, the MVC is a statewide
quality improvement collaborative focused on improving the value of care in Michigan. MVC has developed
and maintained a validated claims-based registry with 90day episodes of care. We obtained all 90-day episodes for
conditions where PCI may have occurred during the index hospitalizations/procedure, which included 90-day
episode of care defined by MVC for 2 clinical episodes:
AMI and PCI. Next, we linked data between the 2 data
sources through indirect matching of the index PCI procedure using multiple variables including hospital and
operator National Provider Identifier numbers, admission, discharge, and procedure dates for the index hospitalization, and patient sex and date of birth.

Study population
The study cohort included all patients who underwent
PCI between January 1, 2013, and March 1, 2018, and
could be matched to 90-day Medicare fee-for-service clin-
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ical episodes (Supplemental Figure S1). The registry allows for multiple race/ethnicity categories to be listed
for a given patient. For this analysis, patients were included if they identified as either "Black/African American" or "White" in the registry, but not both, so that
biracial patients with both "Black/African American" and
"White" categories indicated were excluded. In our final dataset, after excluding biracial patients recorded
as both Black and White race, only 327 (1.12%) patients listed multiple races (ie, Black or White and 1 or
more other race/ethnicity: Asian, NativeAmerican, Native Hawaiain/Pacific Islander, or Hispanic origin). In our
analysis, 318 of these patients were categorized for analysis as White race and 9 as Black race. Race/ethnicity was
collected per the NCDR CathPCI v 4.4 Coder’s data dictionary.21

Outcomes
Primary outcomes included 90-day all-cause readmission and postdischarge long-term mortality. Readmission
was defined as an admission to an acute care hospital for
any reason within 90 days of discharge after the index
PCI. Long-term mortality was obtained from the Medicare beneficiary file using the date of death of the beneficiary. Vital status data were available through December
21, 2019.
Proposed mediators of racial disparities
Based on prior literature, we proposed that the association between race and PCI postdischarge outcomes
may be mediated by individual socioeconomic status,
economic well-being of the patient’s and hospital’s community, in addition to baseline clinical characteristics and
comorbidities, such that these factors are on the pathway through which race may be associated with postdischarge outcomes after PCI (Figure 1). These factors were
chosen as they are known to track with race and have a
plausible association with access to health care that decreases cardiovascular risk.14 , 15 We sought explain this
mediation framework by using sequential analyses to successively account for each of these factors when evaluating the relationship between race and postdischarge outcomes after PCI.
Table I includes a list of variables that were used in the
regression model to represent these 3 mediators. Briefly,
we first created a propensity score model matching on
age and gender which are considered confounders in
the relationships between race and PCI outcomes. Next,
to account for patient-level socioeconomic status, we
included Medicare and Medicaid dual eligibility in the
propensity score (Cohort A).
We subsequently added the distressed communities index (DCI) to the propensity score to account for community economic well-being of the patient and the hospital where the patient underwent PCI (Cohort B). Briefly,
the DCI was created by the Economic Innovation Group
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Figure 1

Potential mediators of racial disparities in postdischarge outcomes after percutaneous coronary intervention. Personal wealth, economic
well-being of the community, and comorbidity burden are acquired throughout lifetime and contribute to differential outcomes following
percutaneous coronary intervention.

Table I. Sequential adjustments to assess proposed mediators of racial disparities

Baseline model
Cohort A
Cohort B
Cohort C

Propensity model

Proposed mediators of racial disparities

Age and gender
Matched on Medicare and Medicaid Dual-Eligibility
Matching as in Cohort A + additional covariate of Distressed
Communities Index (patient and hospital zip code)
Matching as in Cohort B + addition of baseline demographic and
clinical characteristics∗ in propensity score model

—
Personal economic well-being
Economic well-being of health care
community
Patient comorbidities

∗
Glomerular ﬁltration rate, coronary artery disease presentation, cardiogenic shock at start of PCI, cardiogenic shock prior to PCI, peripheral arterial disease, prior PCI,
prior coronary artery bypass graft, prior myocardial infarction, prior congestive heart failure, diabetes, PCI status (elective, urgent, emergent, salvage), current dialysis, left
ventricular ejection fraction, hypertension, dyslipidemia, current tobacco use, chronic lung disease.

to provide comparative measures of economic wellbeing across communities and is a composite ranking
of 7 complementary economic indicators, including education level, housing vacancy, unemployment, poverty
rate, median income, job growth, and business establishments.19,22 The 7 variables are weighted evenly to create
a ZIP code’s rank compared to peers and then normalized to obtain a distress score that ranges from 0 (no distress) to 100 (severe distress). The 2020 edition is built
from the American Communities Survey (ACS) 5-year estimates and the Census Bureau Business Patterns. Lastly,
to account for baseline patient comorbidities, we included several clinical and demographic variables in the
regression model (Cohort C; Supplemental S2). Since comorbidities at the time of presentation for PCI are likely
impacted by race and level of economic deprivation, we
added comorbidities last into our sequential matching in
an effort to analyze how comorbidities mediate the association between race and PCI outcomes, separate from
the effect of socioeconomic factors. A complete description of the mediational model and the steps used can be
found in the Supplemental Methods (S3).

Statistical analysis
Baseline characteristics between Black and White patients were compared using Pearson X2 or Fisher exact
tests for categorical variables and t tests or Wilcoxon
rank sum test for continuous variables. For the analysis of
postdischarge outcomes, propensity score matching and
multivariable logistic regression were used to assess for
any direct and fully or partially mediated effects of race
on these outcomes. A propensity score was developed
using a logistic regression model with race as the outcome and including baseline clinical and demographic
variables as predictors. Black and White patients with
similar propensity scores were then matched 1:1 without replacement within a caliper of 0.25 standard deviations using the greedy algorithm as implemented in the R
package “Matching” to create a matched analysis cohort
where Black and White patients had similar distributions
of age and gender.23
Table 1 includes a full description of the sequential adjustments that were utilized. First, according to the proposed sequential modeling approach, dual enrollment in
Medicare and Medicaid was added as a covariate to the
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propensity score model to account for social risk factors
that may contribute to disparate outcomes, and matching
was repeated to produce a second matched cohort (Cohort A). Next, the DCI of the patient’s and hospital’s zip
code was added to account for the economic well-being
of the community (Cohort B). Lastly, clinical characteristics were added to assess the extent of patient comorbidities on post-PCI outcomes (Cohort C).
Outcome analysis through multivariable logistic and
Cox regression models adjusting for all variables utilized
in matching was performed to assess the extent that the
observed impact of race was reduced or rendered nonsignificant after adjustment, thus implying that the observed racial disparity in the outcome is partially or completely mediated by those variables. R version 3.4.1 was
utilized for all analysis.23

Mediation analysis
Mediation analysis was performed to assess the magnitude by which the proposed mediators explain the association between race and PCI outcomes (90-day readmission and all-cause mortality). The full details of the mediation analysis have been previously described.24–26 Briefly,
we used a weighting approach to assess the effect of
race on PCI outcomes through several mediators considered jointly. We chose a multiple-mediator approach to
account for exposure-mediator and mediator-mediator interaction. Additionally, this approach allows for the magnitude of each mediator to be inferred when applying the
approach sequentially.26
In the weighting approach, the marginal natural direct effect (NDE) size and marginal natural indirect effect (NIE) size were calculated. The NIE size represents
the effect size mediated through each mediator and from
there the proportion mediated (PM) was calculated. The
PM reflects the magnitude of the effect size mediated
by each socioeconomic variable. Bootstrapping was performed for the confidence intervals. R code for the mediation analysis is available upon request.

Results
Patient characteristics
Our study consisted of 30, 206 Medicare fee-for-service
patients undergoing PCI at 48 hospitals across Michigan
between January 2013 and March 2018. Patients who
identified as multiple races, or races other than Black
or White (Asian, Native-American, or Hispanic/Latinx
ethnicity), were excluded (n = 889, 2.9%). Of the remaining patients (n = 29,317), 10.28% were Black and
89.72% were White (Supplemental Figure S1). Black patients were more likely to be female (53.9% vs 38.5%, P
< .001) and more likely to be current or recent smokers
(27.7% vs 19.5%, P < .001). Additionally, Black patients
were more likely to have cardiovascular comorbidities
including hypertension (96.6% vs 88.4%, P < .001), di-
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abetes mellitus (54.8% vs 39.9%, P < .001), peripheral
arterial disease (24.0% vs 17.5%, P < .001) and chronic
kidney disease requiring hemodialysis (8.0% vs 1.7%, P
< .001). Black patients were more likely to present with
non-ST elevation myocardial infarction (30.0% vs 23.9%)
whereas White patients were more likely to present with
stable angina (8.1% vs 10.0%) or unstable angina (43.1 vs
44.8%; P < .001) (Table II).

Process measures and in-hospital outcomes
We also evaluated several hospital process measures.
Black patients were more likely than White patients to
be prescribed clopidogrel (72.5% vs 67.7%, P < 0001;
Table III), whereas White patients were more likely to
be prescribed prasugrel (6.7% vs 10.2%, P < .001). Black
patients were more likely to be prescribed lipid-lowering
agents (94.5% vs 93.2%, P = .021) and beta-blockers for
history of prior myocardial infarction or left ventricular ejection fraction less than 40% (94.4% vs 90.7%, P
< .001) (Table 3). Notably, there was a higher percentage of referrals to cardiac rehabilitation among White patients (58.5% vs 75.2%, P < .001).
Regarding in-hospital outcomes, White patients were
more likely to experience heart failure (2.4% vs 3.2%,
P = .035; Table III), however, Black patients were more
likely to require transfusion (3.6% vs 2.2%, P < .001).
Otherwise, there were no significant differences in inhospital PCI outcomes between Black and White patients. Process measures and in-hospital outcomes for
matched cohorts can be found in Supplemental Table S4.
Ninety-day readmissions
Black patients were significantly more likely than
White patients to be readmitted within 90-days of discharge when accounting for age and gender (adjusted
odds ratio [aOR] 1.62, 95% CI 1.32-2.00; Figure 2). This
association persisted but was attenuated after adjustment
for Medicare and Medicaid Dual eligibility (Cohort A:
aOR 1.55, 95% CI 1.25-1.93) and community economic
well-being (Cohort B: aOR 1.37, 95% CI 1.14-1.63). The
association between race and readmission was rendered
nonsignificant after adjusting for baseline characteristics
and comorbidities (Cohort C: aOR 1.15, 95% CI 0.951.38).
Long-term postdischarge mortality
Median follow-up time for mortality was 3.9 years (interquartile range 2.43-5.46). Black patients had a significantly higher risk of all-cause mortality (adjusted hazard
ratio [aHR] 1.45, 95% CI 1.30-1.61; Figure 3). This relationship was attenuated but still statistically significant
when adjusting for Medicare and Medicaid dual eligibility (Cohort A: aHR 1.34, 95% CI 1.21-1.50; Figure 3) and
community economic well-being (Cohort B: aHR: 1.22
95% CI 1.09-1.37). The association between race and allcause mortality following PCI was further attenuated and
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Table II. Baseline characteristics between Black and White patients, prior to matching

Characteristics
Age, Years (SD)
Male sex, n (%)
Comorbidities, n (%)
Current/recent smoker w/in 1 Y
Hypertension
Dyslipidemia
Family history of premature CAD
Prior MI
Prior heart failure
Prior PCI
Prior CABG
Currently on dialysis
Cerebrovascular disease
Peripheral artery disease
Chronic lung disease
Diabetes mellitus
Coronar y arter y disease presentation, n (%)
No symptoms, no angina
Symptoms, unlikely to be ischemic
Stable angina
Unstable angina
NSTEMI
STEMI or equivalent
Periprocedural variables
Preprocedure creatinine (mg/dL)
Preprocedure hemoglobin (g/dL)
Cardiogenic shock at start of PCI
Intraaortic balloon pump
Other mechanical ventricular support
Arterial access site
Femoral
Radial
Brachial
Other

Black patients (n = 3,015)

White patients (n = 26,302)

P-value

68.9 (10.3)
1390 (46.1)

72.3 (9.4)
16176 (61.5)

<.001
<.001

836 (27.7)
2912 (96.6)
2488 (82.5)
280 (9.3)
997 (33.1)
904 (30.0)
1197 (39.7)
430 (14.3)
242 (8.0)
694 (23.0)
725 (24.0)
714 (23.7)
1651 (54.8)

5130 (19.5)
23246 (88.4)
21761 (82.8)
2969 (11.3)
8009 (30.5)
4594 (17.5)
10985 (41.8)
5122 (19.5)
446 (1.7)
4874 (18.5)
4611 (17.5)
5852 (22.3)
10488 (39.9)

<.001
<.001
.725
.001
.004
<.001
.030
<.001
<.001
<.001
<.001
.079
<.001

89 (3.0)
63 (2.1)
245 (8.1)
1299 (43.1)
904 (30.0)
414 (13.7)

814 (3.1)
787 (3.0)
2641 (10.0)
11786 (44.8)
6290 (23.9)
3979 (15.1)

<.001

1.66 (1.99)
12.27 (1.89)
58 (1.9)
48 (1.6)
53 (1.8)

1.14 (0.81)
13.33 (1.85)
456 (1.7)
316 (1.2)
239 (0.9)

<.001
<.001
.495
.080
<.001

1982 (65.8)
1024 (34.0)
7 (0.2)
1 (0.0)

17056 (64.9)
9160 (34.8)
64 (0.2)
20 (0.1)

.655

Table III. Process measures and in-hospital outcomes between Black and White patients, prior to matching

Process Measures, n (%)
Prescription of antiplatelet
Clopidogrel
Prasugrel
Ticagrelor
Beta-blocker if prior MI or LVEF<40
ACE-I/ARB if LVEF<40% or DM
Lipid lowering agent at discharge
Referral to cardiac rehabilitation
Smoking cessation among eligible pts.
In-Hospital Outcomes, n (%)
Myocardial infarction
Cardiogenic shock
Heart failure
Stroke
RBC/Whole blood transfusion
Bleeding event w/in 72 H

Black patients (n = 3,015)

White patients (n = 26,302)

P-value

2130 (72.4)
196 (6.7)
589 (20.0)
1239 (94.5)
1358 (73.1)
2798 (95.1)
1730 (58.4)
747 (89.4)

17350 (67.6)
2626 (10.2)
5309 (20.7)
9288 (90.8)
9375 (74.2)
23949 (93.3)
19511 (75.4)
4674 (91.2)

<.001
<.001
.410
<.001
.324
<.001
<.001
.094

38 (1.3)
46 (1.5)
73 (2.4)
10 (0.3)
109 (3.6)
108 (3.6)

348 (1.3)
488 (1.9)
837 (3.2)
92 (0.4)
566 (2.2)
881 (3.4)

.838
.224
.025
1.000
<.001
.542

Percentages reported for discharge medications and cardiac rehabilitation referral are calculated excluding from the denominator in-hospital mortality cases, patients
with recorded medication contraindications, and patients recorded as ineligible for rehabilitation. MI=myocardial infarction, LVEF=left ventricular ejection fraction, ACEangiotension coverting enzyme inhibitor, ARB=angiotension receptor blocker, DM=diabetes mellitus, RBC = red blood cells.
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Figure 2

Bar graph depicting odds of 90-day readmission following percutaneous coronary intervention by race for Black (blue) and White (maize)
patients. Odds ratio, conﬁdence interval, and P-value are listed for each cohort. Baseline Cohort: Age and gender, Matched Cohort A:
Medicare and Medical dual eligibility, Matched Cohort B: Cohort A + Distressed Communities Index of hospital & patient community,
Matched Cohort C: Cohort B + baseline demographic and clinical factors. CI, conﬁdence interval; OR, odds ratio.

no longer statistically significant when adjusting for patient comorbidities (Cohort C: aHR 1.01, 95% CI 0.911.11).

Mediation analysis
The proportion-mediated (PM) by each proposed mediator was calculated using the multiple mediation analysis described in the Methods section. Medicare and
Medicaid dual eligibility mediated 11.0% of the association between race and 90-day readmission following PCI
(Figure 4; 95% CI 4.89%-17.37%). The combination of

dual eligibility and community economic status mediated
22.3% of the association (95% CI 12.11%-33.44%). Dual
eligibility, community economic status, and patient comorbidities mediated 45.0% of the association (95% CI
27.00%-60.30%).
Medicare and Medicaid dual eligibility mediated 21.1%
of the observed association between race and 1-year mortality (95% CI 8.24%-35.62%). Dual eligibility and community economic well-being combined mediated 43.0% of
the association (95% CI 24.31%-65.98%). Together all 3
mediators of dual eligibility, community economic well-
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Figure 3

Kaplan-Meier Hazard of long-term mortality following percutaneous coronary intervention for Black (dark gray) and White (light gray)
patients. Hazard ratio and 95% conﬁdence interval are listed for each cohort. Baseline Cohort: Age and gender, Matched Cohort A:
Medicare and Medical dual eligibility, Matched Cohort B: Cohort A + Distressed Communities Index of hospital & patient community,
Matched Cohort C: Cohort B + baseline demographic and clinical factors. CI, conﬁdence interval; HR, hazard ratio.

being, and patient comorbidities mediated 87.8% (95%
CI 60.23%-123.28%).

Discussion
Our study highlights several key findings in the relationship between race and PCI outcomes. First, among
patients undergoing PCI in contemporary practice, there
was minimal difference in in-hospital postprocedure outcomes by race. Second, compared with White patients,
Black patients had a higher risk of 90-day readmission
and long-term mortality after PCI. These associations
were attenuated and no longer statistically significant
after adjusting for dual eligibility, economic well-being
of the patient’s community, and baseline comorbidities.
Lastly, mediation analysis revealed that while dual eligi-

bility and economic well-being of the health care community partially explain the observed racial disparities in
PCI outcomes, comorbidity burden mediates the greatest
proportion of this differential risk.
The present study provides an important advance in
our understanding of racial disparities in outcomes following PCI by evaluating mediators that may lay on the
causal pathway between race and 90-day readmission
and mortality. Prior studies, including a recent analysis
of pooled data from 10 prospective randomized control
trials from Golomb et al, found that risk for adverse clinical outcomes following PCI persists even after adjustment for baseline comorbidities, suggesting race is an
independent predictor of worse outcomes.10 However,
these studies did not account for nontraditional cardiovascular risk factors including personal and community
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Figure 4

Bar graph depicting estimated percent of race effect on 90-day readmission (left) and 1-year mortality (right) mediated by proposed mediators.
Percent mediated is listed above each bar. Proposed mediators are sequentially added from left to right: percent mediated by dual eligibility
(A - dark gray), percent mediated by dual eligibility + community economic status (A+B - gray), percent mediated by dual eligibility,
community economic status, and patient comorbidities (A+B+C - light gray).

economic status, which reflect poverty and potentially poor access to quality health care resulting from
longstanding policies and practices that systematically
marginalize Black patients.27 As a result of structural
racism, Black patients experience a higher burden of
detrimental social determinants of health so these risk
factors must be accounted for to adequately address
risk of adverse outcome following PCI.28 , 29 Our study
uniquely adds to our understanding of the relationship
between race and PCI outcomes by applying a mediation framework to understand the magnitude of impact
of not only traditional cardiovascular risk factors, but also
a range of personal and community social determinants
of health – including personal wealth, insurances status,
economic distress of the community (capturing employment rates, poverty rate, education level, and housing
vacancy of the community) – which all have prominent
roles in evaluation and management of CAD across the
care continuum. It is possible that our study has even
underestimated the association of socioeconomic factors
and cardiovascular outcomes as our sample includes only
patients who underwent PCI, a procedure with barriers
to access for minority patients.5 , 30
While our study supports the role of economic disadvantage in differential outcomes by race, the data also
suggests that comorbidity burden continues to mediate the largest proportion of the observed racial disparities in PCI outcomes. Our study utilized a similar framework to an analysis from Kobayashi et al
which used sequential adjustment to assess the influ-

ence of comorbidities, socioeconomic status, and sitelevel racial breakdown on post-PCI outcomes between
Black and White patients treated at US Veterans Affairs
Hospitals. The authors found that baseline comorbidities primarily account for differences in unadjusted mortality difference.14 Our sequential regression approach
showed similar results, in which the relationship between race and 90-day readmission and cumulative mortality was rendered statistically nonsignificant by adjustment for baseline clinical characteristics and comorbidities. Additionally, our mediation framework demonstrated that baseline comorbidities had the greatest magnitude of impact on the observed racial disparities in
90-day readmission and cumulative morality following
PCI. It remains difficult to disentangle the role of baseline clinical risk from economic factors as these mediators are likely highly interrelated with bidirectional
effects.30 Lower socioeconomic status portends worse
health, just as illness undermines financial security and
economic opportunity, especially within communities
of color.31 To address this complexity, we utilized a
multiple mediator approach in our study, which is designed to address mediator-mediator interaction,26 although it is possible that the impact of baseline comorbidities is still overestimated and in some part due
to the economic consequences of poor health. Preventive efforts must nevertheless begin with traditional risk
factor modification and address the complex social, environmental, and behavioral factors that contribute to
them.
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While our data demonstrated racial disparities in 90day readmission and mortality, there were minimal differences in process measures and in-hospital outcomes.
The main difference observed in peri-procedural care
was a lower rate of prasugrel use in Black patients,
which reflects previous studies showing underutilization
of newer P2Y12 inhibitors in this population and may
be due to socioeconomic and insurance factors.15 , 32 We
also noted that compared with White patients, Black patients were less likely to receive a referral to cardiac
rehabilitation prior to hospital discharge. This finding
requires further investigation to understand the potential factors leading to this important disparity. However,
Black patients were slightly more likely than White patients to receive other guideline-directed medical therapy, including beta blockers and lipid-lowering agents,
but otherwise, there were no major differences in inhospital PCI process measures. While earlier studies
assessing racial disparities in PCI outcomes found differences in periprocedural care and prescription of
evidence-based-treatments,33 our contemporary study
shows more marked disparities in longer-term outcomes
rather than differences at the time of care.1 This could
reflect improving adherence to well-established inpatient guidelines for treatment of acute coronary syndrome and coronar y arter y disease. Our findings are
aligned with prior studies that have found little opportunity for improvement in PCI-specific process measures, which are poorly correlated with hospital variation in long-term outcomes.33 , 34 Future studies that characterize care in the outpatient setting are needed to
better understand the difference in postdischarge outcomes.
Our study findings highlight the important opportunity for reducing disparities outside of the acute hospital setting, including the critical need to address gaps
in pre- and postprocedural care, which are often a result of social determinants of health, including personal
and community-level poverty.17 , 35 From a prevention
standpoint, policies need to reinforce and expand programs that have been developed to reduce the burden of
chronic cardiovascular conditions, including obesity, hypertension, chronic kidney disease, and diabetes mellitus, in minority groups. Enhanced care coordination and
patient navigation, which have been studied in the oncology patient population, are important for managing complex comorbidities that are often rooted in social risk and
can be applied to the cardiovascular care setting.36–38
Health care teams can also address disparities by promoting pathways out of poverty and eliminating barriers
to access through transportation support, elimination of
co-pays and collaboration with social support agencies.
Ongoing cultural competence and implicit bias training
for our cardiovascular providers is also paramount38–40 ;
it is possible the observed differences we saw in rate of
cardiac rehabilitation referrals may reflect unconscious

racial biases that impact referral patterns. Deeper investigation into the potential causes of important healthcare disparities, such as the difference in rates of cardiac rehabilitation referral, is required. Finally, cardiovascular providers must continue to use data and registries
to monitor outcomes, identify disparities, and track the
effectiveness of such interventions over time.

Limitations
Our findings should be taken in the context of some
important limitations. As an observational study, our analysis is subject to unmeasured confounding; however, we
were able to account for a wide range of demographic,
clinic, and procedural variables by merging clinical registry and administrative claims data. Second, we categorized race as Black and White, which does not account
for other racial minorities (eg, Latinx, Asian/Pacific Islander, Native American) or those who identify as biracial or multiracial. Third, despite using a multicenter registry that includes hospitals across diverse geographic areas, our findings are limited to a single state and may not
be generalizable to other states. Fourth, we only used 1
variable to account for patient-level socioeconomic status, however, Medicare and Medicaid dual eligibility has
been previously used as a measure of a mix of social, economic, and functional health factors in prior studies.41 , 42
Lastly, all hospitals participate in the BMC2 collaborative
quality improvement initiative for PCI. As a group, we
share best practices and routinely evaluate quality of care
measures with ongoing quality improvement projects.43
Thus, engagement in these quality improvement activities may limit the generalizability of our findings to other
states without such collaborative quality improvement
programs.

Conclusions
We found that Black patients had a higher risk of 90-day
readmission and cumulative mortality following PCI compared with White patients. These associations were mediated by personal socioeconomic status, economic wellbeing of the health care community, and to the greatest extent, baseline comorbidity burden. Hospitals and
policymakers need to invest in programs that not only
promote prevention of disease, but also address disparities in postacute care and outcomes to mitigate the adverse health outcomes associated with socioeconomic
status and community factors. Future research is needed
to identify and evaluate interventions that address these
mediators to promote health equity in PCI outcomes.
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